scholarly journals Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: Comparison with PET-CT

2012 ◽  
Vol 81 (8) ◽  
pp. 1917-1925 ◽  
Author(s):  
Guglielmo Manenti ◽  
Carmelo Cicciò ◽  
Ettore Squillaci ◽  
Lidia Strigari ◽  
Ferdinando Calabria ◽  
...  
Keyword(s):  
Tumor Staging ◽  
Whole Body ◽  
Whole Body Mri ◽  
Pet Ct

Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas.

2016 ◽  
Vol 85 (2) ◽  
pp. 313-318 ◽  
Author(s):  
Domenico Albano ◽  
Caterina Patti ◽  
Ludovico La Grutta ◽  
Francesco Agnello ◽  
Emanuele Grassedonio ◽  
...  
Keyword(s):  
Diffusion Weighted Imaging ◽  
Whole Body ◽  
Newly Diagnosed ◽  
Whole Body Mri ◽  
Diffusion Weighted ◽  
Pet Ct

scholarly journals Current role of CT and whole body MRI in multiple myeloma

2013 ◽  
Vol 94 (2) ◽  
pp. 169-183 ◽  
Author(s):  
R. Duvauferrier ◽  
M. Valence ◽  
S. Patrat-Delon ◽  
E. Brillet ◽  
E. Niederberger ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Whole Body ◽  
Whole Body Mri ◽  
Current Role

Diagnostic challenges in neoplastic meningitis presenting as intracranial hypertension

2021 ◽  
Vol 14 (3) ◽  
pp. e238808
Author(s):  
Santosh Sriram Andugulapati ◽  
Akash Chheda ◽  
Karan Desai ◽  
Sangeeta Hasmukh Ravat
Keyword(s):  
Cerebrospinal Fluid ◽  
Intracranial Hypertension ◽  
Neoplastic Meningitis ◽  
Whole Body ◽  
Csf Cytology ◽  
Csf Analysis ◽  
Pet Ct ◽  
Pet Ct Scan ◽  
Systemic Malignancy

A diagnosis of idiopathic intracranial hypertension should be considered only after careful exclusion of all possible aetiologies. We report a case of neoplastic meningitis presenting as intracranial hypertension with inconclusive repeated cerebrospinal fluid (CSF) cytology and MRI of brain, emphasising the importance of meticulous CSF analysis and role of early whole-body PET–CT scan for diagnosis of systemic malignancy.

Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer

2008 ◽  
Vol 113 (6) ◽  
pp. 895-904 ◽  
Author(s):  
E. Pelosi ◽  
V. Arena ◽  
A. Skanjeti ◽  
V. Pirro ◽  
A. Douroukas ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Whole Body ◽  
Disease Detection ◽  
Biochemical Relapse ◽  
Radical Treatment ◽  
Choline Pet ◽  
Pet Ct

scholarly journals Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas

2020 ◽  
Vol 13 (2) ◽  
pp. 94-98 ◽  
Author(s):  
Francesco Bertagna ◽  
Domenico Albano ◽  
Elisabetta Cerudelli ◽  
Maria Gazzilli ◽  
Raffaele Giubbini ◽  
...  
Keyword(s):  
Case Reports ◽  
Case Series ◽  
Whole Body ◽  
Cochrane Library ◽  
Whole Body Imaging ◽  
Mri Imaging ◽  
Psma Pet ◽  
Pet Ct ◽  
Diagnostic Role

Background: Radiolabeled prostate-specific membrane antigen PSMA-based PET/CT or PET/MRI is a whole-body imaging technique currently performed for the detection of prostate cancer lesions. PSMA has been also demonstrated to be expressed by the neovasculature of many other solid tumors. Objective: The aim of this review is to evaluate the possible diagnostic role of radiolabeled PSMA PET/CT or PET/MRI in patients with gliomas and glioblastomas, by summarizing the available literature data. Methods: A comprehensive literature search of the PubMed/MEDLINE, Scopus, Embase and Cochrane library databases was conducted to find relevant published articles about the diagnostic performance of radiolabeled PSMA binding agents in PET/CT or PET/MRI imaging of patients with suspected gliomas or glioblastomas. Results: Seven case reports or case series and 3 studies enrolling more than 10 patients showed that gliomas and glioblastoma are PSMA-avid tumors. Conclusion: Radiolabeled PSMA imaging seems to be useful in analyzing glioma/glioblastoma. Further studies enrolling a wider population are needed to clarify the real clinical and diagnostic role of radiolabeled PSMA in this setting and its possible position in the diagnostic flow-chart.

Sign in / Sign up

Export Citation Format

Share Document